Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence
Antonio Passaro, Albrecht Stenzinger, Solange Peters
Topics & Concepts
PembrolizumabImmunotherapyBiomarkerCancer immunotherapyMedicineCancerCompanion diagnosticCancer researchOncologyInternal medicineBiologyGeneticsCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsPancreatic and Hepatic Oncology Research